This study is to our knowledge the largest to date to characterize the risks of breast cancer mortality according to Ki67 score and the first to examine its prognostic value in routine care in more than 20 centers without the use of a central laboratory for determination of Ki67 scores. The gene discussed is MKI67; the disease is breast cancer.